Keyphrases
Confidence Interval
100%
Retrospective Cohort Study
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
United States Veterans
100%
Body Composition Changes
100%
Lymphoma Survivors
100%
Adjusted Odds Ratio
50%
Sarcopenia
25%
Visceral Obesity
25%
Long-term Development
25%
Visceral Fat Area
25%
Sarcopenic Obesity
25%
Prednisone
12%
Repeated Measures Analysis of Variance
12%
Clinical Risk Factors
12%
Logistic Regression
12%
Statistical Test
12%
Weight Gain
12%
Weight Loss
12%
Rituximab
12%
Clinical Variables
12%
Doxorubicin
12%
Subcutaneous Fat
12%
Cyclophosphamide
12%
Patients at Risk
12%
Lifestyle Intervention
12%
Retrospective Cohort
12%
Body Composition Parameters
12%
Long-term Health Outcomes
12%
Variance Regression
12%
Subcutaneous Fat Area
12%
Muscle Area
12%
Computed Tomography Analysis
12%
Fat Gain
12%
Medicine and Dentistry
Retrospective Cohort Study
100%
Sarcopenia
100%
Lymphoma Cell
100%
Odds Ratio
100%
Diffuse Large B-Cell Lymphoma
75%
Subcutaneous Fat
50%
Visceral Fat
50%
Analysis of Variance
25%
Computer Assisted Tomography
25%
Logistic Regression Analysis
25%
Rituximab
25%
Health Outcomes
25%
Lifestyle Intervention
25%
Doxorubicin
25%
Cyclophosphamide
25%
Prednisone
25%
Vincristine
25%
Agricultural and Biological Sciences
Confidence Interval
100%
Veterans
100%
Body Composition
100%
Sarcopenia
50%
Odds Ratio
50%
B Cell
37%
Visceral Fat
25%
Subcutaneous Fat
25%
Risk Factor
12%
Computed Tomography
12%
Analysis of Variance
12%
Weight Gain
12%
Rituximab
12%
Vincristine
12%
Prednisone
12%
Nursing and Health Professions
Confidence Interval
100%
Cohort Analysis
100%
Body Composition
100%
Odds Ratio
50%
Sarcopenia
50%
Diffuse Large B Cell Lymphoma
37%
Logistic Regression Analysis
12%
Computer Assisted Tomography
12%
Health Outcomes
12%
Analysis of Variance
12%
Prednisone
12%
Rituximab
12%
Doxil
12%
Vincristine
12%
Cyclophosphamide
12%